VRX.CA
Bausch Health Cos., Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · CA
Sep 10, 2026, 12:12 UTC
SCYNEXIS Inc. appointed Sanjay Subramanian as Chief Financial Officer effective September 9, 2026.
Source:Sep 8, 2026, 12:00 UTC
Bausch Health and YUN announced an expansion of their collaboration to bring microbiome-friendly skincare products to Mexico and additional EMEA markets, including the Czech Republic, Slovakia, Ukraine, Bulgaria, and Kazakhstan.
Source:Aug 12, 2026, 22:30 UTC
Bausch Health Companies Inc. reported Q2 2026 non-GAAP EPS of $1.26, beating consensus by $0.25, with 13% revenue growth and improved margins and cash flow.
Source:Aug 6, 2026, 11:04 UTC
Thomas J. Appio, CEO of Bausch Health, was appointed to the board of directors of Bausch + Lomb Corporation, effective August 5, 2026.
Source:Jul 29, 2026, 20:05 UTC
Bausch Health Companies Inc. announced its second quarter 2026 financial results on July 29, 2026.